In conclusion, our findings presented preliminary evidence that XPC c.2815A>C, XPD c.934G>A, XPD c.2251A>C and ERCC1 c.354C>T SNPs alter clinical outcome of HNSCC patients treated with CDDP chemoradiation. Here, ERCC2 is linked to head and neck squamous cell carcinoma.